Alterity Therapeutics (ATHE) Current Leases (2020 - 2025)

Alterity Therapeutics' Current Leases history runs 6 years deep, the most recent figure standing at $42980.1 for Q4 2025.

• On a quarterly basis, Current Leases rose 4.8% year-over-year to $42980.1 in Q4 2025; TTM through Dec 2025 was $42980.1, a 4.8% increase from a year earlier, with the FY2025 full-year figure at $56707.2, down 19.68% from the prior year.
• Current Leases retreated to $42980.1 in Q4 2025 per ATHE's latest filing, from $56707.2 in the prior quarter.
• Across five years, Current Leases topped out at $56707.2 in Q2 2025 and bottomed at $1071.3 in Q2 2024.
• The 5-year median for Current Leases is $41011.6 (2024), against an average of $29355.4.
• Across the five-year window, Current Leases tumbled 97.4% in 2023 and surged 5193.25% in 2025, its largest moves.
• Year by year, Current Leases stood at $21365.9 in 2021, then surged by 93.2% to $41280.0 in 2022, then plunged by 97.4% to $1071.8 in 2023, then surged by 3726.53% to $41011.6 in 2024, then advanced by 4.8% to $42980.1 in 2025.
• Per Business Quant, the three latest ATHE Current Leases figures stand at $42980.1 (Q4 2025), $56707.2 (Q2 2025), and $41011.6 (Q4 2024).